ArticleBiotechnology and applied biochemistry2026
Biocidal Activity of Barium and Iron-Co-Doped Titanium Dioxide Nanocomposites, Synthesized by Psidium guajava-Mediated Precipitation Method.
Article in Biotechnology and applied biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The emergence of drug-resistant microorganisms and the need for effective anticancer agents necessitate the development of novel nanomaterials with enhanced biomedical performance. This study aims to synthesize barium and iron dual-doped titanium dioxide (TiBaFeO NC) using a green precipitation method with Psidium guajava leaf extract, targeting improved antimicrobial and anticancer efficacy. The synthesized nanocomposite was characterized by various analytical techniques. XRD confirmed the crystalline anatase phase of TiO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.